Biocorrx (OTCMKTS:BICX) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Biocorrx (OTCMKTS:BICX – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02, Zacks reports. The business had revenue of ($0.04) million for the quarter, compared to the consensus estimate of $0.25 million.

Biocorrx Price Performance

Shares of BICX opened at $0.21 on Tuesday. The firm’s 50 day simple moving average is $0.22 and its 200 day simple moving average is $0.30. The company has a market capitalization of $6.41 million, a P/E ratio of -1.74 and a beta of 0.07. Biocorrx has a 1-year low of $0.15 and a 1-year high of $1.28.

Biocorrx Company Profile

(Get Free Report)

BioCorRx, Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence. The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

Read More

Earnings History for Biocorrx (OTCMKTS:BICX)

Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.